PCM
CDMO

Portolan Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Portolan Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-455,038
Closed -$5.62M – 151
2024
Q4 		$5.62M Sell
455,038
-1,638,953
-78% -$18.8M 0.38% 82
2024
Q3 		$23.8M Buy
2,093,991
+273,212
+15% +$2.74M 1.73% 14
2024
Q2 		$13M Buy
1,820,779
+953,894
+110% +$7.3M 1.07% 27
2024
Q1 		$5.81M Buy
866,885
+428,283
+98% +$2.95M 0.44% 80
2023
Q4 		$2.85M Buy
+438,602
New +$2.83M 0.25% 96
2023
Q1 		– Sell
-35,108
Closed -$483K – 174
2022
Q4 		$483K Sell
35,108
-29,201
-45% -$447K 0.05% 128
2022
Q3 		$1.23M Sell
64,309
-127,862
-67% -$2.33M 0.13% 121
2022
Q2 		$2.93M Sell
192,171
-26,954
-12% -$399K 0.3% 101
2022
Q1 		$4.46M Buy
219,125
+3,110
+1% +$63.3K 0.36% 90
2021
Q4 		$6.3M Buy
216,015
+119,611
+124% +$3.42M 0.42% 77
2021
Q3 		$2.08M Sell
96,404
-221,149
-70% -$5.34M 0.15% 117
2021
Q2 		$8.14M Sell
317,553
-273,679
-46% -$5.85M 0.59% 67
2021
Q1 		$10.8M Sell
591,232
-527,390
-47% -$8.76M 0.85% 45
2020
Q4 		$12.9M Buy
1,118,622
+155,248
+16% +$1.42M 1.17% 23
2020
Q3 		$7.34M Buy
963,374
+528,662
+122% +$4M 0.83% 47
2020
Q2 		$2.85M Buy
+434,712
New +$2.43M 0.33% 97

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Portolan Capital Management's CDMO Position: Q1 2025 in Review

Portolan Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 455,038 shares — an estimated $5.62M sold.

Portolan Capital Management first reported a position in CDMO in Q2 2020 and held it in 16 quarters. The position peaked at $23.8M in Q3 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Portolan Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Portolan Capital Management sold 455,038 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $5.62M.
  • Portolan Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • Portolan Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $23.8M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Portolan Capital Management's 13F filing for Q1 2025, filed 15 May 2025.